论文信息 - De-Escalating Breast Cancer Surgery for Low-Risk Ductal Carcinoma in Situ-Reply. - 字舞流文

De-Escalating Breast Cancer Surgery for Low-Risk Ductal Carcinoma in Situ-Reply.

E. Winer | M. Morrow

[1] E. Winer,et al. De-escalating Breast Cancer Surgery-Where Is the Tipping Point? , 2019, JAMA oncology.

[2] Daniel F. Hayes,et al. 20‐Year Risks of Breast‐Cancer Recurrence after Stopping Endocrine Therapy at 5 Years , 2017, The New England journal of medicine.

[3] P. Cordeiro,et al. Bilateral Mastectomy versus Breast-Conserving Surgery for Early-Stage Breast Cancer: The Role of Breast Reconstruction , 2015, Plastic and reconstructive surgery.

[4] H. Bartelink,et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5] T. Julian,et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. , 2011, Journal of the National Cancer Institute.

[6] Angela Fagerlin,et al. Patient involvement in surgery treatment decisions for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.